封面
市场调查报告书
商品编码
1638754

顺势疗法药物治疗市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Homeopathy Medicine Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球顺势疗法药物治疗市场估值为93 亿美元,预计2024 年至2032 年复合年增长率为12%。其最小的副作用而受到追捧。将顺势疗法融入全球(尤其是欧洲和亚洲)的医疗保健系统,为市场扩张做出了重大贡献。此外,政府的支持性政策、顺势疗法药物的供应增加以及专科诊所的不断增加也增强了该行业的实力。

市场分为几个产品类别,包括稀释剂、酊剂、片剂和胶囊、颗粒剂、乳膏剂和软膏剂、鼻喷雾剂等。其中,稀释业务占最大份额,预计在预测时间内复合年增长率为 11.9%。这个细分市场的主导地位植根于顺势疗法的核心原则,顺势疗法使用高度稀释的物质来刺激身体的自然癒合机制。这些疗法以其安全性和温和的效果而闻名,对那些寻求自然疗法治疗需要长期治疗的慢性病的人来说很有吸引力。

美国在北美顺势疗法市场中占据显着地位,预计将保持这一领先地位,2023 年复合年增长率为11.7%。患病率推动的。受此类疾病影响的人数不断增加,进一步扩大了顺势疗法的市场,顺势疗法为控制疼痛和促进整体健康提供了安全有效的选择。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 93亿美元
预测值 254亿美元
复合年增长率 12%

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 对顺势疗法选择的认识不断提高
      • 慢性病盛行率增加
      • 在新兴市场越来越受欢迎
    • 产业陷阱与挑战
      • 常规药物和替代药物的可用性
  • 成长潜力分析
  • 监管环境
  • 消费者行为分析
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 稀释液
  • 酊剂
  • 片剂和胶囊
  • 颗粒剂
  • 乳霜和软膏
  • 鼻喷剂
  • 其他产品

第 6 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 镇痛解热
  • 胃肠病学
  • 呼吸系统
  • 神经病学
  • 皮肤科
  • 其他应用

第 7 章:市场估计与预测:按来源划分,2021 - 2032 年

  • 主要趋势
  • 植物性
  • 矿物基
  • 以动物为基础

第 8 章:市场估计与预测:按类型,2021 - 2032

  • 主要趋势
  • 处方
  • 场外交易

第 9 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 10 章:公司简介

  • A Nelson & Co
  • Ainsworths
  • Bahola
  • Biologische Heilmittel
  • BJain Pharmaceuticals
  • Boiron
  • Dr. Willmar Schwabe
  • Hahnemann Laboratories
  • Heel
  • Hevert - Arzneimittel
  • Homeocan
  • Medisynth
  • Powell Laboratories
  • SBL
  • Wheezal Homoeo Pharma
简介目录
Product Code: 12127

The Global Homeopathy Medicine Treatment Market was valued at USD 9.3 billion in 2023 and is projected to expand at a CAGR of 12% from 2024 to 2032. This robust growth is driven by the increasing preference for homeopathic treatments, which are sought after for their minimal side effects and natural approach to healing.Rising awareness about the effectiveness of homeopathy in managing chronic and lifestyle-related conditions is a key factor fueling market growth. The integration of homeopathic practices into healthcare systems globally, particularly in Europe and Asia, is contributing significantly to the market expansion. In addition, supportive government policies, greater availability of homeopathic medicines, and the growing presence of specialized clinics strengthen the sector.

The market is divided into several product categories, including dilutions, tinctures, tablets and capsules, granules, creams and ointments, nasal sprays, and others. Among these, the dilutions segment holds the largest share and is expected to grow at a CAGR of 11.9% during the forecast timeframe. This segment's dominance is rooted in the core principles of homeopathy, which use highly diluted substances to stimulate the body's natural healing mechanisms. These remedies are known for their safety and gentle effects, making them appealing to those seeking natural treatments for chronic conditions requiring long-term management.

The U.S. holds a prominent position in the North American homeopathy market and is expected to maintain this lead, with a CAGR of 11.7% in 2023. The demand for alternative treatments is notably driven by the high prevalence of chronic health conditions, especially arthritis, which leads many individuals to seek non-toxic, natural treatment alternatives. The increasing number of people affected by such conditions is further expanding the market for homeopathic remedies, which offer a safe and effective option for managing pain and promoting overall wellness.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$9.3 Billion
Forecast Value$25.4 Billion
CAGR12%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising awareness related to homeopathic treatment options
      • 3.2.1.2 Increasing prevalence of chronic diseases
      • 3.2.1.3 Growing popularity in emerging markets
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of conventional and alternative medicines
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Consumer behaviour analysis
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Dilutions
  • 5.3 Tinctures
  • 5.4 Tablets & capsule
  • 5.5 Granules
  • 5.6 Creams & ointments
  • 5.7 Nasal spray
  • 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Analgesic and antipyretic
  • 6.3 Gastroenterology
  • 6.4 Respiratory
  • 6.5 Neurology
  • 6.6 Dermatology
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By Source, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Plant-based
  • 7.3 Mineral-based
  • 7.4 Animal-based

Chapter 8 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prescription
  • 8.3 OTC

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 A Nelson & Co
  • 10.2 Ainsworths
  • 10.3 Bahola
  • 10.4 Biologische Heilmittel
  • 10.5 BJain Pharmaceuticals
  • 10.6 Boiron
  • 10.7 Dr. Willmar Schwabe
  • 10.8 Hahnemann Laboratories
  • 10.9 Heel
  • 10.10 Hevert - Arzneimittel
  • 10.11 Homeocan
  • 10.12 Medisynth
  • 10.13 Powell Laboratories
  • 10.14 SBL
  • 10.15 Wheezal Homoeo Pharma